Current therapies such as biological DMARDs showed promising results in treating rheumatoid arthritis patients, and market penetration is expected to be more in the future and expected to drive market ...
When your body’s immune cells attack you instead of protecting you, today’s treatments tamp down the friendly fire but they ...
GENEVA (Reuters) - The World Health Organization said on Friday it had added its first monoclonal antibody tocilizumab to its so-called pre-qualification list, an official list of medicines used as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback